(Q48907572)

16 February 2018

title

Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer. (English)

1 reference

16 February 2018

Adaptive radiation therapy

main subject

0 references

1 reference

Hans Geinitz

1

1 reference

16 February 2018

Reinhard Thamm

2

1 reference

16 February 2018

Christian Scholz

3

1 reference

16 February 2018

Christine Heinrich

4

1 reference

16 February 2018

Nina Prause

5

1 reference

16 February 2018

Simone Kerndl

6

1 reference

16 February 2018

Monika Keller

7

1 reference

16 February 2018

Raymonde Busch

8

1 reference

16 February 2018

Michael Molls

9

1 reference

16 February 2018

Frank B Zimmermann

10

1 reference

16 February 2018

publication date

28 December 2009

1 reference

16 February 2018

Strahlentherapie und Onkologie

published in

1 reference

16 February 2018

volume

186

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

page(s)

46-52

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/s00066-009-2023-7

exact match

0 references

cites work

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis. A prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

A phase II randomized study of topical intrarectal administration of amifostine for the prevention of acute radiation-induced rectal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

The clinical significance of quality of life assessments in oncology: a summary for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

RTOG's first quality of life study—RTOG 90-20: A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Fatigue during breast radiotherapy and its relationship to biological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

3D conformal radiation therapy for prostate cancer in elderly patients

21 January 2018

1 reference

12 December 2020

Fatigue in patients with cancer. Analysis and assessment

1 reference

12 December 2020

Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer

1 reference

12 December 2020

Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy)

1 reference

12 December 2020

Dose-Response Relations for Anal Sphincter Regarding Fecal Leakage and Blood or Phlegm in Stools after Radiotherapy for Prostate Cancer

1 reference

12 December 2020

Single-institution results of primary external-beam radiation for the treatment of t1-t3 prostate cancer

1 reference

12 December 2020

Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial

1 reference

12 December 2020

The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer

1 reference

12 December 2020

Quality of life changes during conformal radiation therapy for prostate carcinoma

1 reference

12 December 2020

Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer

1 reference

12 December 2020

Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00066-009-2023-7

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018